Titles and Roles
- Assistant Professor, Department of Radiation Oncology
- Emory University School of Medicine
- Medical Student Clerkship Director
- Department of Radiation Oncology
- Adjunct Assistant Professor
- Georgia Institute of Technology
- Research Program
- Discovery and Developmental Therapeutics
Mohammad K. Khan, MD, PhD, specializes in the treatment of lymphoma, leukemia, multiple myeloma, skin (melanoma, squamous cell, basal cell, merkel cell), and pediatric cancers. Dr. Khan is board certified in Radiobiology/Physics by the American Board of Radiology.
Dr. Khan is a member of the American College of Radiology, American Brachytherapy Society, American Society for Therapeutic Radiation Oncology, American College of Radiation Oncology and American Society of Clinical Oncology. He serves as a board member of the Georgia Radiological Society; is a vice chair of the Radiation Safety Committee for Human Use at Emory; and is an active member of the ACRIN/ECOG melanoma committee.
Dr. Khan fluently speaks English, Urdu, Hindi and is familiar with Spanish and Arabic.
Prior to medical school, Dr. Khan received two BS degrees, one in Nuclear Engineering and one in Biology with a minor in Biochemistry & Molecular Biology. Both degrees were awarded with Summa Cum Laude distinction. He then completed his MS, and PhD degrees in Nuclear Engineering with emphasis on health and medical physics from the University of Tennessee, Knoxville. His graduate research focused on the use of innovative imaging technologies, such as PET and MRI, to improve radiation treatment planning for emerging cancer therapeutics such as boron neutron capture therapy for patients with malignant brain tumors.
Dr. Khan did his residency training in radiation oncology at the Cleveland Clinic, Cleveland, OH. He completed a fellowship in ABS Prostate Bracytherapy at the Seattle Prostate Institute and an internship in medicine and surgery at the Cleveland Clinic.
During his residency training, he received several academic accolades including the Roentgen Resident/Fellow Research Award for Outstanding Radiological Research, the Scott Hamilton CARES Initiative Research Grant to fund a prospective phase I prostate cancer IGRT study, American College of Radiation Oncology Travel Award, American Brachytherapy Society Fellowship Award, and the American Society of Therapeutic Radiation Oncology Translation and Imaging Symposium Travel Award.
Dr. Khan continues to be actively engaged in a wide variety of cancer related research, including designing new clinical trials, enrolling patients on existing trials, developing patient databases to look at treatment outcomes, and engineering new mathematical and physics solutions to improve existing technologies such as IMRT (Intensity Modulated Radiotherapy) and IGRT (Image Guided Radiotherapy).
Dr. Khan has collectively authored over 73 abstracts, manuscripts, commentaries, and book chapters. He has presented at national and international conferences.